Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Eli Lilly in the Drug Discovery & Development Pharma 50

Eli Lilly

Rank: 14

2021 Rank: 14

Indianapolis, United States
www.lilly.com

2021 Revenues ($USD) : $28,318,400,000
2021 R&D spend : $7,025,900,000
2021 Number of Employees : 35,238
Fiscal Year End : 12/31/2021
Leader : CEO David Ricks

Founded in 1876, Eli Lilly had revenue growth of 10% for 2021, excluding COVID-19 antibodies. Growth drivers include Trulicity (dulaglutide), Taltz (ixekizumab), Jardiance (empagliflozin), Verzenio (abemaciclib) and Olumiant (Baricitinib). The Indianapolis-based company makes drugs for diabetes, oncology, immunology, neurosciences and other therapies, including COVID-19 treatment therapies. Lilly’s COVID-19 antibody bebtelovimab has so far demonstrated its resilience to emerging SARS-CoV-2 variants, including the BA.2 subvariant of the omicron variant. Also in 2021, the company noted continued progress with its five top molecules in its pipeline, which include tirzepatide, donanemab, pirtobrutinib, mirikizumab and lebrikizumab. —BB

Eli Lilly Corporate Center

[Image courtesy of Wikipedia]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE